Steve Kirsch Introducing the members of the NIH COVID-19 Treatment Guidelines committee Summary The members of COVID-19 Treatment Guidelines Panel of the NIH apparently doesn’t seem to place any value on human life. In this article, I will show several examples of this. At no time is there ever a risk-benefit analysis where a dollar amount is placed on the value of a human life. For example, if there are 100 trials and 90% of the trials were positive and 10% were neutral, should the NIH recommend the drug? Unfortunately, they aren’t…
